Thanks Jeanne! Lil
>>A Canadian-developed cancer drug based on a shark cartilage extract will
>>undergo clinical testing at hospitals in Canada and the United States
>>starting next year. Officials at Quebec City based AEterna
>>Laboratories, Inc. said the drug, Neovastat, will probably be tested on
>>about 500 patients with advanced prostate and lung cancer. AEterna
>>officials said the extract from the backbone of the spiny dogfish, a
>>shark species found in both the Atlantic and Pacific oceans, is designed
>>to prevent the formation of new blood vessels needed to nourish
>>turmors. AEterna said the National Cancer Institute in Bethesda, Md.
>>selected Neovastat for trials that will be funded and supervised by the
>>U.S. government-backed body to evaluate the effectiveness of shark
>>cartilage extract in treating cancer.
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
